Liverpool care pathway offers no added benefits over usual care for dying patients, finds studyBMJ 2013; 347 doi: https://doi.org/10.1136/bmj.f6200 (Published 15 October 2013) Cite this as: BMJ 2013;347:f6200
- Zosia Kmietowicz
The Liverpool care pathway provides the same quality of care as that usually provided to cancer patients who are dying in hospital, a study has found.1
The authors say that because care under the pathway is no better than standard care any initiative to replace the pathway in England should be “grounded in scientific evidence” and tested in controlled trials before it is implemented.
In a commentary on the study, David Currow, from Flinders University in Adelaide, Australia and Amy Abernethy, from Duke Clinical Research Institute in the United States, say, “Across healthcare there is a need to improve care for people who are dying, which has led to widespread uptake of the …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial